U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07454148) titled 'CART-BP Prospective Study for Hypertension Control' on March 02.
Brief Summary: This prospective, open-label, non-randomized study evaluates the effectiveness and safety of a CART BP pro-guided blood pressure management strategy in Korean patients with uncontrolled hypertension. Participants are allocated to either a CART BP pro-guided management group or a usual care group based on clinical decision and participant preference. The primary efficacy endpoint is 24-hour mean ambulatory systolic blood pressure at 24 weeks; safety outcomes including treatment-emergent adverse events (TEAE) are also assessed.
Study Start Date: March 25,...